ニュース、リソース、最新情報
当社の最新の研究動向や企業情報をお届けする科学情報拠点です。
Press Release: InnoSer and Neurix form a partnership to offer neural organoids for oncology drug development applications
Press release | Leiden, 25 January 2021 InnoSer and Neurix form a partnership to offer neural organoids for oncology drug development applications Commercial availability of the in vitro glioblastoma Minibrain organoid platform paves the way for personalized...
InnoSerの上級研究員、サラ・アーツの一日
創薬開発を加速する革新的なツール群を提供するため、InnoSerは科学とビジネスの両分野の専門家を結集しています。インタビューシリーズ「ある1日」を通じて、この小さな組織の一員となる日常を垣間見てみましょう...
InnoSerの「Organ-on-Chip」製品マネージャー、アレックス・バスティアンスの一日
創薬開発を加速する革新的なツール群を提供するため、InnoSerは科学とビジネスの両分野の専門家を結集しています。インタビューシリーズ「ある1日」を通じて、この小さな組織の一員となる日常を垣間見てみましょう...
InnoSer offers in vivo and in vitro imaging capabilities
InnoSer is acquiring a variety of preclinical imaging modalities for its Diepenbeek facility to offer its customers a comprehensive assessment of their models and compounds. Non-invasive and high-throughput kinetic assays with real-time readouts will improve screening...
InnoSer welcomes Edith Simar as its new Business Development Manager
Starting from September 2020, Edith Simar joined the InnoSer team as a business development manager. Thanks to her earlier work and connections in Belgium, France, and Luxembourg Edith will especially strengthen InnoSer’s relationships with (prospective) French...
ハビエル・ハラゾ氏による中脳オルガノイドに関する無料ウェビナー
InnoSer is inviting all interested in using midbrain organoids as a platform for Parkinson's disease drug development to its webinar organized in collaboration with OrganoTherapeutics. The presentation outlining the platform characteristics and use will be given by...
info@innoserlaboratories.com